How Mycotoxins Impact Chicks’ Incubation and Hatch 

Low hatchability, reduced egg quality, and impaired chick immunity are common hatchery-related challenges, and it is possible that mycotoxins could be the culprit. 

Mycotoxins are unavoidable contaminants in feed that have negative effects on bird health. They are present in poultry diets worldwide, but due to their often-invisible effects, mycotoxins are frequently overlooked in parent stock farms, with the negative outcomes appearing at the hatcheries. Mycotoxins can negatively impact a diversity of indices that are necessary for the success of breeder and hatchery production: fertility, eggshell quality, efficiency of vaccine response, and quality of the progeny. Becoming informed and aware of this challenge and how to protect your birds is key to helping them reach their maximum genetic potential and, consequently, maximizing the economic success of your hatchery.

Mycotoxins negatively impact a diversity of indices connected to the performance of the breeders and their chicks and consequently affect economic indices such as:

Impaired performance of breeders and roosters

Zearalenone (ZEN) has a similar chemical structure to the hormone estrogen and is usually related to reproductive disorders. The presence of ZEN in breeder diets can modify the physiology of the reproductive tract by inducing hyperactivity of the ovaries and cystic oviducts. These alterations reflect in lower fertility rates, egg production, and hatchability of eggs. Ochratoxin (OTA) is another mycotoxin that alters embryo development, decreasing chick livability and reducing the progeny’s ability to fight infections.

Reduced egg quality

Mycotoxins such as toxin T-2, OTA, and ZEN influence eggshell formation through different modes of action: reduced calcium absorption, changes in the protein synthesis, and/or modification of the reproductive physiology in such a way that breeders and layers are not able to produce high-quality eggs. Lower quality eggs result in fewer eggs hatching, reducing the hatchery’s overall production output. Measurements that quantify the changes in egg quality due to mycotoxins include: reduced Haugh units, height of the albumen, and egg weight as well as reduced eggshell thickness and alterations in egg size.

Impaired yolk formation and reduced chick livability

The liver is responsible for lipid metabolism, which is directly correlated with the yolk formation and formation of liposoluble vitamins. The most common pathological lesions associated with mycotoxicosis in poultry are found in the liver. When liver function of the breeder hen is impaired, there is a direct link to impaired yolk formation. Since the yolk is a key component in the nutrition and health of a developing chick, this results in higher initial chick mortality.

Predisposition to ‘leaky gut’ and contamination through the hatchery

Deoxynivalenol (DON) and fumonisins (FUM) have a large impact on gut integrity. They influence the formation and functionality of tight junctions, a multi-protein complex established between closely connected intestinal cells that maintains a barrier between the gut lumen and the blood circulation. Both mycotoxins contribute to an increased permeability causing ‘leaky gut’ syndrome. As a result, the proliferation of intestinal pathogens, i.e., Salmonella sp, may also be increased. Moreover, liquid excreta leads to a higher percentage of dirty eggs, which reduces the overall hygienic status of the hatchery.

Impaired immunity and vaccine failure

Even at moderate levels of contamination, mycotoxins are considered immunosuppressive agents and are capable of downregulating antibodies and immunoglobulins synthesis. These mechanisms are attributed to mycotoxins including Aflatoxin, trichothecenes, FUM, and OTA. Their presence can be considered a driver of failure in vaccine programs. Several studies have shown that Fusarium mycotoxins such as DON reduce antibody titers for Newcastle disease and the infectious bronchitis virus in breeders.

Published on

23 October 2023

Tags

  • Poultry
  • Mycotoxins

Not all products are available in all markets nor associated claims allowed in all regions (including but not limited to USA and Canada).

Related Articles

  • Q4 2025 Vitamin Market Update

    Q4 2025 Vitamin Market Update

    15 Sep 2025

    As Q4 approaches, the global vitamin market remains anything but predictable. Shaped by shifting supply dynamics, tariffs, and evolving demand, the landscape is a mix of softness and tightening across segments. While some vitamins remain oversupplied and under pressure, others are showing signs of recovery or volatility. In this outlook, we explore the key trends, pricing movements, and strategic considerations buyers must weigh to navigate the final quarter of 2025 effectively.

  • Optimizing Animal Productivity: Evaluating the Strategic Role of 25-hydroxycholecalciferol

    Optimizing Animal Productivity: Evaluating the Strategic Role of 25-hydroxycholecalciferol

    15 Sep 2025

    Vitamin D, specifically cholecalciferol (Vitamin D3), is a critical nutrient involved in calcium and phosphorus metabolism across all livestock species. It can be supplied through endogenous synthesis in the skin via ultraviolet (UV) light exposure or, more commonly in modern production systems, through dietary supplementation. The use of 25-hydroxycholecalciferol (25-OH D3) for diet supplementation, which is the predominant circulating metabolite of Vitamin D3 required for physiological functions, has become standard practice in swine and poultry nutrition due to its superior bioavailability and metabolic efficiency.

  • Mycotoxin Outlook for 2025 Harvest – Part 1

    Mycotoxin Outlook for 2025 Harvest – Part 1

    15 Sep 2025

    Variable = one good word to describe planting and growing conditions for the 2025 crop year. This is true across the country and applies within locations too as variable temperature and precipitation patterns have occurred this year. Realistically, that’s not that unusual but it seems like more places have gone from one extreme to the other since spring. The USDA recently released record yield projections (188.8 bushels per acre) and increased acres of corn planted to the highest acreage since 1937. Despite the record production projections, there are rumblings from the field about disease pressures in various areas which could limit the potential for a record harvest. Mycotoxins can occur even when yields are good. So, what mycotoxins could we expect in new crops knowing conditions have varied and there is disease out there? This article is the first in a series sharing insights into potential mycotoxin contamination patterns in the 2025 corn crop.

Share

You are being redirected.

We detected that you are visitng this page from United States. Therefore we are redirecting you to the localized version.